JCO clinical cancer informaticsHumansCarcinomaNon-Small-Cell LungLung NeoplasmsMale
Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer.
Jyoti Malhotra, Shilpa Viswanathan, Shivani K Mhatre, Inderjit K Dhillon, Riddhi Patel, Nicole Yohn, Furaha Kariburyo-Yay, Xinye Li, Biagio Ricciuti
Published: 202610.1200/CCI-25-00207
Abstract
PURPOSE: This study examined real-world overall survival (rwOS) in patients with advanced or metastatic non-small cell lung cancer (a/mNSCLC) treated with combination immunotherapy (IO) and platinum chemotherapy in first line (1L), followed by second…
Preview only. Read the full abstract at the source